Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

(2010) B. Glintborg et al.   ANNALS OF THE RHEUMATIC DISEASES

Biological Therapy for Psoriatic Arthritis in Clinical Practice: Outcomes Up to 2 Years

(2010) L. M. VIRKKI et al.   JOURNAL OF RHEUMATOLOGY

Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort

(2010) Laura C. Coates et al.   ARTHRITIS CARE & RESEARCH

Remission in psoriatic arthritis: is it possible and how can it be predicted?

(2010) Tajvur P Saber et al.   ARTHRITIS RESEARCH & THERAPY

Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT

(2010) Dafna D Gladman et al.   ARTHRITIS RESEARCH & THERAPY

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

(2009) F Van den Bosch et al.   ANNALS OF THE RHEUMATIC DISEASES

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

(2009) Merete Lund Hetland et al.   ARTHRITIS AND RHEUMATISM

Psoriatic arthritis assessment and treatment update

(2009) Philip J Mease   CURRENT OPINION IN RHEUMATOLOGY

New biologics for psoriasis and psoriatic arthritis

(2009) Mariya Rozenblit et al.   Dermatologic Therapy

Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis

(2009) M. RUDWALEIT et al.   JOURNAL OF RHEUMATOLOGY

The Challenge and Need of Defining Axial Psoriatic Arthritis

(2009) J. L. FERNANDEZ-SUEIRO   JOURNAL OF RHEUMATOLOGY

An open-source, self-explanatory touch screen in routine care. Validity of filling in the Bath measures on Ankylosing Spondylitis Disease Activity Index, Function Index, the Health Assessment Questionnaire and Visual Analogue Scales in comparison with paper versions

(2009) David B. Schefte et al.   RHEUMATOLOGY

Capturing real-life patient care in psoriatic arthritis and its risks: the challenge of analysing registry data

(2009) Daniel Aletaha   ARTHRITIS RESEARCH & THERAPY

Persistence with anti-tumor necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

(2009) Amr A Saad et al.   ARTHRITIS RESEARCH & THERAPY

The occurrence of psoriatic arthritis in Denmark

(2008) O B V Pedersen et al.   ANNALS OF THE RHEUMATIC DISEASES

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

(2008) M L Hetland et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment recommendations for psoriatic arthritis

(2008) C T Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

(2008) Marte Schrumpf Heiberg et al.   ARTHRITIS AND RHEUMATISM